Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M162,931Revenue $M42,237Net Margin (%)27.0Altman Z-Score3.3
Enterprise Value $M177,716EPS $4.1Operating Margin %12.5Piotroski F-Score5
P/E(ttm)15.0Beneish M-Score-3.1Pre-tax Margin (%)40.0Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %5.4Quick Ratio1.3Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %4.0Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow18.9y-y EBITDA Growth Rate %75.5ROA % (ttm)10.9Higher Current Ratio y-yN
Dividend Yield %3.1PEG3.8ROE % (ttm)23.3Less Shares Outstanding y-yY
Payout Ratio %46.0Shares Outstanding M2,825ROIC % (ttm)6.5Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKVanguard Health Care Fund 2015-03-31 Add0.53%$56.06 - $63.03
($59.34)
$ 57.67-3%Add 12.04%40,096,948
MRKDodge & Cox 2015-03-31 Reduce-0.44%$56.06 - $63.03
($59.34)
$ 57.67-3%Reduce 24.30%25,448,977
MRKKahn Brothers 2015-03-31 Reduce-0.22%$56.06 - $63.03
($59.34)
$ 57.67-3%Reduce 2.18%1,029,815
MRKJoel Greenblatt 2015-03-31 Reduce-0.17%$56.06 - $63.03
($59.34)
$ 57.67-3%Reduce 35.28%676,758
MRKJames Barrow 2015-03-31 Add0.13%$56.06 - $63.03
($59.34)
$ 57.67-3%Add 7.03%24,464,116
MRKCharles Brandes 2015-03-31 Reduce-0.07%$56.06 - $63.03
($59.34)
$ 57.67-3%Reduce 3.69%2,221,791
MRKNWQ Managers 2015-03-31 Reduce-0.01%$56.06 - $63.03
($59.34)
$ 57.67-3%Reduce 9.00%76,286
MRKMario Gabelli 2015-03-31 Add0.01%$56.06 - $63.03
($59.34)
$ 57.67-3%Add 11.45%160,943
MRKKen Fisher 2015-03-31 Add$56.06 - $63.03
($59.34)
$ 57.67-3%Add 0.59%6,679,499
MRKKahn Brothers 2014-12-31 Reduce-0.54%$53.43 - $61.88
($58.42)
$ 57.67-1%Reduce 5.08%1,052,807
MRKVanguard Health Care Fund 2014-12-31 Add0.32%$53.43 - $61.88
($58.42)
$ 57.67-1%Add 7.08%35,788,048
MRKJoel Greenblatt 2014-12-31 Add0.23%$53.43 - $61.88
($58.42)
$ 57.67-1%Add 94.88%1,045,652
MRKFirst Eagle Investment 2014-12-31 Reduce-0.16%$53.43 - $61.88
($58.42)
$ 57.67-1%Reduce 99.16%9,050
MRKJoel Greenblatt 2014-09-30 Add0.24%$55.64 - $61.18
($58.89)
$ 57.67-2%Add 323.00%536,550
MRKFirst Eagle Investment 2014-09-30 Reduce-0.1%$55.64 - $61.18
($58.89)
$ 57.67-2%Reduce 38.25%1,083,826
MRKKahn Brothers 2014-09-30 Reduce-0.09%$55.64 - $61.18
($58.85)
$ 57.67-2%Reduce 0.97%1,109,189
MRKCharles Brandes 2014-09-30 Reduce-0.08%$55.64 - $61.18
($58.85)
$ 57.67-2%Reduce 4.69%2,320,288
MRKVanguard Health Care Fund 2014-09-30 Reduce-0.07%$55.64 - $61.18
($58.85)
$ 57.67-2%Reduce 1.38%33,420,748
MRKRobert Bruce 2014-09-30 Add0.06%$55.64 - $61.18
($58.85)
$ 57.67-2%Add 1.34%265,000
MRKDodge & Cox 2014-09-30 Reduce-0.05%$55.64 - $61.18
($58.85)
$ 57.67-2%Reduce 2.51%35,057,668
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schechter Adam HEVP & Pres-Global Human Health 2015-05-11Sell10,634$60.44-4.58view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2015-05-08Sell38,368$60.99-5.44view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-05-04Sell56,064$60.2-4.2view
Holston Michael JEVP, Legal 2015-04-29Sell95,624$59.84-3.63view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-04-29Sell156,902$59.82-3.59view
FRAZIER KENNETH CChairman, President & CEO 2015-02-18Sell5,164$58.67-1.7view
Deese Willie AExe V-P & Pres. MMD 2015-02-11Sell135,864$58.56-1.52view
WENDELL PETER CDirector 2015-02-09Sell5,000$58.76-1.86view
Schechter Adam HEVP & Pres-Global Human Health 2015-01-15Sell74,200$62.48-7.7view
FRAZIER KENNETH CChairman, President & CEO 2015-01-09Sell8,840$62.47-7.68view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

    News about MRK:

    Articles On GuruFocus.com
    Intrexon Corp is expanding his business Jun 25 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 
    Risk & Reward with Gilead Sciences Inc. (GILD) May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    Robert Bruce's Top Growth Stocks Apr 13 2015 
    Gilead Experiencing Bumpy Ride Despite Strong Fundamentals Apr 03 2015 

    More From Other Websites
    Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount Jul 03 2015
    Hospira wins French biosimilar drug tender at 45 pct discount Jul 03 2015
    Even though I got a rare reaction to a routine shot, I'm still pro-vaccine Jul 02 2015
    2015 Forbes Women's Summit: Full Session Videos Jul 02 2015
    J&J vaccine completely prevented HIV in half of monkeys in trial Jul 02 2015
    Why Illumina The "Marvel" May See a Stock Rise Jul 02 2015
    US stocks open higher as Street eyes jobs, Greece Jul 02 2015
    Glenmark gets US regulator nod for cholesterol drug Jun 30 2015
    German Merck expanding presence in Israel with acquisitions Jun 29 2015
    Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection... Jun 29 2015
    Merck To Fully Acquire Israeli Quantum Materials Company Qlight Nanotech Jun 29 2015
    A Makeover at the ‘Other’ Merck Jun 26 2015
    The 4 Stocks That Lifted the Dow on Friday Jun 26 2015
    Merck to Hold Second-Quarter 2015 Sales and Earnings Conference Call on July 28 Jun 26 2015
    Merck to Hold Second-Quarter 2015 Sales and Earnings Conference Call on July 28 Jun 26 2015
    Short Sellers Become More Focused on Big Pharma Jun 25 2015
    Merck Launches “More than a Mother” Campaign Aiming to Reduce Social Suffering of Infertile... Jun 23 2015
    How Apple, Google and 7 Other Cash-Hoarding Companies Will Spend Their Billions Jun 23 2015
    Merck (MRK) Stock Closed Up on Encouraging New Drug Pipeline Jun 22 2015
    Merck Serono’s MSdialog Wins Readers Choice Category of 2015 Medical Design Excellence Award... Jun 22 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK